| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| abatacept | activation b7-1 antigen | NA | Successful target | TTD , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Graft-vs-Host Disease[MeSHID:D006086] Arthritis Psoriatic[MeSHID:D015535] Juvenile arthritis[MeSHID:D001171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
42.43 | approved | unknown |
| abatacept | t-lymphocyte activation antigen cd80 | biotech | NA | drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Graft-vs-Host Disease[MeSHID:D006086] Arthritis Psoriatic[MeSHID:D015535] Juvenile arthritis[MeSHID:D001171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
42.43 | approved | antagonist |
| abatacept | t-lymphocyte activation antigen cd80 | biotech | NA | drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Graft-vs-Host Disease[MeSHID:D006086] Arthritis Psoriatic[MeSHID:D015535] Juvenile arthritis[MeSHID:D001171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
42.43 | approved | antagonist,inhibitor |
| abatacept | activation b7-1 antigen | NA | Successful target | TTD , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Graft-vs-Host Disease[MeSHID:D006086] Arthritis Psoriatic[MeSHID:D015535] Juvenile arthritis[MeSHID:D001171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
42.43 | approved | inhibitor |
| abatacept | t-lymphocyte activation antigen cd86 | biotech | Successful target | TTD , drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Graft-vs-Host Disease[MeSHID:D006086] Arthritis Psoriatic[MeSHID:D015535] Juvenile arthritis[MeSHID:D001171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
42.43 | approved | antagonist,inhibitor |
| abatacept | t-lymphocyte activation antigen cd86 | biotech | Successful target | TTD , drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Graft-vs-Host Disease[MeSHID:D006086] Arthritis Psoriatic[MeSHID:D015535] Juvenile arthritis[MeSHID:D001171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
42.43 | approved | antagonist |
| click here to return to the previous page | ||||||||